Charles River Laboratories International Inc (NYSE:CRL)
| 155.57 Delayed Data As of 6:30pm ET |  -2.82 / -1.78%Today’s Change | 123.17 Today|||52-Week Range 179.38 | +1.84% Year-to-Date |
Latest CRL News | Press Releases
No recent news for Charles River Laboratories International Inc.
Today’s Trading
| Previous close | 158.39 |
| Today’s open | 153.25 |
| Day’s range | 152.55 - 157.01 |
| Volume | 773,008 |
| Average volume (3 months) | 347,374 |
| Market cap | $8.5B |
Data as of 6:30pm ET, 02/28/2020
Growth & Valuation
| Earnings growth (last year) | +9.54% |
| Earnings growth (this year) | +11.89% |
| Earnings growth (next 5 years) | +11.00% |
| Revenue growth (last year) | +15.67% |
| P/E ratio | 30.7 |
| Price/Sales | 2.88 |
| Price/Book | 5.20 |
Competitors
| Today’s change | Today’s % change | |
|---|---|---|
| ICLRICON PLC | -0.62 | -0.40% |
| SYNHSyneos Health Inc | +0.61 | +0.97% |
| PRAHPRA Health Sciences ... | -0.06 | -0.06% |
| EXELExelixis Inc | +0.17 | +0.92% |
Data as of 3:59pm ET, 02/28/2020
Financials
| Next reporting date | May 6, 2020 |
| EPS forecast (this quarter) | $1.56 |
| Annual revenue (last year) | $2.6B |
| Annual profit (last year) | $252.0M |
| Net profit margin | 9.61% |
Profile
Sector Commercial Services |
Industry Miscellaneous Commercial Services |
No executives to display |
Corporate headquarters Wilmington, Massachusetts |
Forecasts
